UPSTREAM BIO, INC. (UPB) Net Margin
- 2026-06-30: Net Margin -5136.09%.
- 2026-03-31: Net Margin -3925.63%.
- 2025-12-31: Net Margin -6356.14%.
- 2025-09-30: Net Margin -4941.14%.
Complete source-backed net margin history.
- Available history
- 2023-09-30 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -5136.09% |
| 2026-03-31 | -3925.63% |
| 2025-12-31 | -6356.14% |
| 2025-09-30 | -4941.14% |
| 2025-06-30 | -4265.31% |
| 2025-03-31 | -4818.02% |
| 2024-12-31 | -3465.25% |
| 2024-09-30 | -2634.60% |
| 2024-06-30 | -2878.04% |
| 2024-03-31 | -1702.19% |
| 2023-12-31 | -2629.56% |
| 2023-09-30 | -499.52% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -5026.03% |
| 2024-12-31 | -2650.04% |
| 2023-12-31 | -862.90% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |